Syamsudin Abdillah,Ph.D, Pharm D
2 clinical trials · Sponsor
◉ Watch Syamsudin Abdillah,Ph.D, Pharm D
| Record | Firm | Date |
|---|---|---|
| Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency (NCT05829187) | Syamsudin Abdillah,Ph.D, Pharm D | 2022-11-01 |
| Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua (NCT06036030) | Syamsudin Abdillah,Ph.D, Pharm D | 2019-01-11 |
Track Syamsudin Abdillah,Ph.D, Pharm D automatically
Every clearance here is in the API, with alerts when new ones post.